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Friend leukemia virus (1)  is a  type C  murine retrovirus that has rapid effects on 
erythropoiesis. The original isolate of Friend leukemia virus complex (FV-A)1 induces 
splenomegaly, the proliferation of mononuclear cells, and anemia (2). Subsequently, 
a  variant of the anemia-inducing strain of Friend virus was isolated from stocks of 
FV-A  by Mirand  (3).  This  isolate of Friend  leukemia virus complex  (FV-P)  also 
induces splenomegaly and the rapid proliferation of mononuclear cells in susceptible 
mice. However, in contrast to the leukemia induced by FV-A, the disease associated 
with  FV-P  is  characterized  by  polycythemia and  the  rapid  appearance  of large 
numbers  of cells capable  of erythroid differentiation both  in  vivo  (4)  and  in  cell 
culture (5, 6) in the absence of added erythropoietin (EPO). 
Preparations  of FV-P  contain  both  a  replication-defective  transforming  virus, 
designated spleen focus-forming virus  (SFFVe)  (7),  and  a  helper murine leukemia 
virus, F-MuLVp, that provides functions necessary for SFFVp to complete its repli- 
cative cycle (8-10).  Although an SFFV has been  reported  in some stocks of FV-A 
(11),  its relationship to SFFVp, and possible role in the pathogenesis of the erythro- 
leukemia induced by FV-A, is not clear. 
In this and the accompanying study (12),  the erythroleukemic potential of clonal 
isolates of both the replication-defective viruses, SFFVA and SFFVp;  and the repli- 
cation-competent viruses, F-MuLVA and F-MuLVp present  in stocks of FV-A and 
FV-P,  have been  analyzed. We reasoned that  the availability of related isolates of 
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Friend leukemia virus that apparently induce different disease states may be useful in 
understanding the  role of viral functions in leukemic hemopoiesis. The results pre- 
sented  in  this  study  demonstrate  that  at  least  two  related,  but  biologically and 
molecularly distinguishable, forms  of SFFV  can  be  obtained  after  cloning in  rat 
fibroblasts. 
Materials and Methods 
Mice.  Female mice of strain DBA/2J, aged 6-10 wk, and female F1 hybrids produced by 
crossing mice of strains WC/Re-Steel (Sl)/+ and C57BL/6J-+/Sl a (WCB6F1) or WB/Re-W~ 
+ and C57BL/6J-+/W  v (WBB6F1) were obtained from The Jackson Laboratory, Bar Harbor, 
Maine. Each of these crosses yields mice of four different genotypes: +/+, Sl/+, +/Sl a, and Sl/ 
V  v  d  v  SI d or +/+,  W/+,  +/W  and  W/W . Mice of the SI/SI  and  W/W  genotypes have severe 
macrocytic anemia; mice of the other genotypes have normal (+/+)  or near-normal (Sl/+, 
+/SI d,  W/+, +/W v) phenotypes. Mice congcnic at the Fv-2 locus,  B6.S, and C57BL/6 (B6) 
mice,  were  obtained by serial intercrosses  and backcrosses  with  the  Friend leukemia virus- 
sensitive SIM strain (13). B6 mice are Fv-2 rr, whereas B6.S mice are Fv-2 sS. These mice were 
bred at the Division of Laboratory Animal Science, University of Toronto, Toronto, Canada, 
and were obtained from Dr. A. Axelrad, University of Toronto. 
Culture Conditions.  NIH/3T3 cells (14) and RAT-1 cells (15), obtained from Dr. B. Ozanne, 
University of Toronto, were maintained in minimum essential medium (a-MEM) (16), without 
nucleosides,  that was supplemented with  10%  fetal  calf serum (KC Biological, Inc., Lenexa, 
Kans.). Cells were routinely passaged by trypsinization every 3  4 d. 
Virus and Virus Assays.  NB-tropic FV-A, passaged in vivo and prepared from the enlarged 
spleens of Swiss mice, was  originally obtained from  Dr.  C.  Friend. The spleen extract  was 
passaged  in  DBA/2J  mice,  and  a  spleen extract  from  these  mice was  then  used  to  infect 
NIH/3T3 cells as described previously (9). These cells were cloned immediately after infection 
in microtiter wells, passaged in vitro for several  months, cloned again, and a stable clone that 
released  into the cell culture fluids at least 2 ×  103 focus-forming units (FFU)/ml of SFFVA was 
selected. SFFVA and SFFVp tilers, in FFU/ml, were determined in DBA/2J mice by the spleen 
focus assay method (7). The isolation of NIH/3T3 cells productively infected with NB-tropic 
FV-P has  been previously described  (9). Clonal  isolates  of F-MuLVA and  F-MuLVp were 
obtained after end point dilution of FV-A and FV-P, respectively and infection of NIH/3T3 
cells,  as  described  in the  accompanying study  (12). Tilers of F-MuLVA and  F-MuLVp in 
plaque-forming units  (PFU)/ml  were  determined  by  the  XC  plaque  assay  as  described 
previously (17). Clones of RAT-1 cells nonproductively infected with SFFVA or SFFVr,  were 
isolated as described previously (9). Briefly, RAT-1 fibroblast cells were infected with FV-A at 
a multiplicity of 1 PFU and 0.025  FFU per cell or with FV-P at 0.24  PFU and 2.4 FFU per 
cell. After 3 h, the cells were cloned at 0.25 cells/well in microtiter wells. Nonproducer clones 
were identified by superinfection with F-MuLV as described previously (9). Virus was rescued 
from RAT-1 nonproducer clones by superinfection with F-MuLV at a multiplicity of 0.1 PFU/ 
cell. Culture fluids containing rescued virus were  harvested after the cells had been passaged 
four times. 
Culture of Erythroid Colonies.  Cells were cultured in 0.8% methylcellulose-containing  Iscove's 
modified Dulbecco's medium (lot  No.  430-2200;  Grand Island Biological  Co.,  Grand Island, 
N. Y.). Each  1.0-ml culture contained 1 ×  105 nucleated bone marrow or spleen cells,  7.5  X 
10  -5 M 2-mercaptoethanol, and 10% fetal calf serum (lot No. 4055899;  Flow Laboratories, Inc., 
Rockville,  Md.)  (18, 19). EPO  (step  III,  lot  No.  3025-1;  Connaught  Medical  Research 
Laboratories, Willowdale, Ontario, Canada) was added at the outset ofcuhure where indicated. 
After 2 d  of incubation, colonies of eight  or more erythroid cells  were  scored  using a  light 
microscope  (magnification: ×  100). At least two cultures were prepared for each experimental 
point in each assay. 
Competition Immunoassays.  Competition immunoassays were  performed by analysis of unla- 
beled antigens, at serial  twofold  dilutions, for ability to compete with  125I-labeled Rauscher- 
routine leukemia virus structural proteins, p30,  p15,  pl0, p12, and gp70,  for binding limiting 
amounts of goat antiserum directed against detergent-disrupted FV-P isolated from chronically MACDONALD ET AL.  1479 
infected  NIH/3T3 cells (9). Proteins  were  purified  and  12hi-labeled according to previously 
described procedures (20). Competition immunoassay reaction mixtures contained 0.01 M Tris- 
HC1, pH 7.8, 1.0 mM EDTA, 0.4% Triton X-100 (Rohm and Haas Co., Philadelphia,  Pa.),  1% 
bovine serum  albumin, and 0.2 M  NaCI in a  total vol of 0.2 ml. Antiserum  and unlabeled 
competing antigen were incubated at 37°C for 1 h followed by the addition of 10,000 cpm 1251- 
labeled antigen.  After further incubation for 3 h at 37°C and  18 h at 4°C, antigen-antibody 
complexes were immunoprecipitated as previously described  (20). 
Immunoprecipitation and Sodium Dodecyl Sulphate (SDS)-Polya~lamide  Gel Electrophoresis (SDS- 
PAGE).  Exponentially  growing  cells Were labeled  with  [  S]methionine  (1,075 Ci/mmol, 
Amersham  Corp.,  Arlington  Heights,  I11.) as  previously  described  (21). After  labeling,  cell 
monolayers  were  washed  twice  with  serum-free  medium  and  disrupted  at  4°C  in  10  mM 
sodium phosphate,  pH 7.2, 0.9% NaCI,  1% Triton X-100, 0.5% sodium deoxycholate, and 0.1% 
SDS (PBSTDS) lysis buffer. Cell extracts  (1 ml) were incubated at 4°C for 18 h after addition 
of RNase A (200 #g/ml), RNase T2 (0.1 #g/ml), DNase I (4.0 #g/ml), normal goat serum  (5 
#1), protein-A Sepharose CI-4B (1.0 ml of 10% wt:vol suspension) (Pharmacia Fine Chemicals, 
Div. of Pharmacia, Inc., Piscataway,  N. J.), and clarified by centrifugation  for 1 h at  100,000 
g.  Viral-specific  proteins  were  immunoprecipitated  by  incubation  for  18  h  at  4°C  in  the 
presence of 5 #! of specific antisera,  addition of 50 #1 of 10% (vol/vol) protein-A  Sepharose CI- 
4B suspension, and incubation for a further 2 h at 4°C. Immunocomplexes were collected by 
centrifugation  at 2,000 g for  10 min, washed three  times in PBSTDS and analyzed by SDS- 
PAGE on 5-20% polyacrylamide  gradient  slab gels (21). 
Two-Dimensional Tryptic Peptide Analysis.  Viral-specific proteins  were purified  by immuno- 
precipitation  and SDS-PAGE and subjected to tryptic peptide  analysis as previously described 
(21). Samples  resuspended  in  electrophoresis  buffer  (acetic acid:formic acid:water,  15:5:80) 
were spotted  on  10-  ×  10-cm cellulose-coated  thin-layer  chromatography glass plates  (EM 
Laboratories,  Inc., Elmsford, N. Y.). Eleetrophoresis was performed  for 30 min at 500 V, and 
chromatography was conducted in  the  second dimension  in  buffer  that  contained butanol, 
pyridine, acetic acid, and water (32:25:5:20). Radiolabeled  tryptic peptides were visualized by 
autoradiography using Kodak X-Omat XR2 film (Eastman  Kodak Co., Rochester,  N. Y.) as 
previously described  (21). 
Results 
Infection  of Mice  with  FV-A  Derived from  NIH/3T3  Fibroblasts.  To  facilitate  the 
comparative studies  to  be  described,  clones of NIH/3T3 cells  chronically infected 
with  FV-A or  FV-P were  established  as  described  in  Materials  and  Methods.  To 
determine whether the FV-A produced by fibroblasts elicits anemic transformation in 
vivo as described previously, DBA/2J mice 6 wk of age were injected with supernatant 
fluid from these fibroblast cultures and hematocrits, spleen weight, and the number 
of spleen foci were assayed on day 0, 7-10, 14-16, and 25-35. DBA/2J mice were also 
injected  with  FV-P  produced  by  chronically  infected  NIH/3T3  fibroblasts  (9)  to 
provide a  comparison of the  leukemogenic,  focus-forming ability  and  hematologic 
effects of these two strains of Friend leukemia virus.  As shown in Table I, stocks of 
FV-A  passaged  in  DBA/2J  mice  contained  low  titers  of a  spleen  focus-forming 
activity, SFFVA. The morphology of the spleen foci induced by FV-A were different 
from those induced by FV-P and exhibited a more flattened and diffuse morphology. 
Individual  spleen  foci  produced  by  either  FV-A  or  FV-P  were  obscured  late  in 
infection  by  large  increases  in  spleen  weight  (Table  I).  The  data  in  Table  I  also 
indicate that the cell-culture-derived FV-A induced progressive anemia, whereas the 
cell-culture-derived FV-P induced polycythemia, similar  to animal-passaged prepa- 
rations of FV-A and FV-P. 
To examine further the ability of FV-A harvested  from NIH/3T3 cells  to induce 
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TABLE  I 
Properties of Cell Culture-derived FV-A and FV-P* 
Time after  Spleen  Virus  Hematocrit  Number of foci/spleen  infection  weight 
d  %  g 
7- l0  Mock~:  50  0.1  0 
FV-P  52  0.6  80 
FV-A (in vivo)  50  0.4  38 
FV-A (cell culture)  50  0.4  50 
14-16 
25-35 
Mock  49  0.1  0 
FV-P  65  2.6  Confluent§ 
FV-A (in vivo)  44  1.4  Confluent 
FV-A (cell culture)  43  1.9  Confluent 
Mock  51  0.1  0 
FV-P  89  3.9  Confluent 
FV-A (in vivo)  39  2.6  Confluent 
FV-A (cell culture)  37  3.0  Confluent 
* FV-A and FV-P were obtained from cloned NIH/3T3 fibroblasts that chronically produce these viruses 
or, where indicated, from spleen extracts from FV-A passaged only in vivo in DBA/2J mice as described 
in Materials and Methods. DBA/2J  mice were injected intravenously on  day 0.  Hematocrits were 
determined using blood obtained from the tail vein.  The virus titers were determined using the spleen 
focus assay (7). 
:~ Mock-infected  mice received similar amounts ofcuhure fluid from uninfected NIH/3T3 cells. 
§ Confluent spleens were too enlarged to count individual foci. 
FV-A. Infected mice were killed at day 9 and their spleens examined for macroscopic 
foci. As shown in Fig. 1 c, the spleens of mice that received low dilutions of FV-A were 
greatly enlarged, whereas those receiving higher dilutions exhibited discrete foci (Fig. 
1 b). Furthermore, as shown in Fig. 2, the number of spleen foci was linearly related 
to the dilution of FV-A. 
Erythroid  Progenitor Cells in  FV-A- and  FV-P-infected  DBA/2J  Mice.  Polycythemic 
transformation by FV-P is characterized by EPO-independent erythropoiesis in vivo 
(4), and by the appearance of cells in the marrows and spleens of FV-P-infected mice 
that are capable of forming erythroid colonies in semisolid medium in the absence of 
added EPO (5, 6). To determine whether infection with FV-A also alters the sensitivity 
of erythroid progenitor cells to  EPO,  bone marrow  and spleen cells were plated  in 
methylcellulose culture in the  presence or  absence of added  EPO  at  various times 
after 6-wk-old DBA/2J  mice had been infected with FV-A. As shown in Fig. 3, the 
number of EPO-dependent erythroid colony-forming cells in the  marrow of FV-A- 
infected  mice continued to  decrease  during infection and colony formation in  the 
absence of added EPO was not observed. In contrast, erythroid colony-forming cells 
were detected both in the presence and in the absence of added EPO in FV-P-infected 
marrow at day 8  and their numbers continued to increase with time after infection. 
The number of EPO-dependent erythroid colony-forming cells in the spleens of FV- 
A or FV-P-infected mice increased early after infection (days 8-10) and continued to 
rise to very high numbers. Infection with FV-P rapidly resulted in the appearance of 
EPO-independent erythroid colonies, whereas only low numbers of EPO-independent 
colony-forming cells were observed in FV-A infected spleens very late after infection 
(days 25-35). MACDONALD  ET  AL.  1481 
Fro.  1.  Spleens of mock-infected and FV-A infected DBA/2J Mice. Spleens from DBA/2J  mice- 
injected intravenously 9  d  previously with  (a)  undiluted  supernate  from  NIH/3T3  cells  (mock- 
infected), 0a)  10  -a dilution of supernate from NIH/3T3  fibroblasts chronically infected with FV-A, 
and (c)  10  -t dilution of supernate from NIH/3T3  fibroblasts chronically infected with FV-A. 1482  ANEMIA- AND  POLYCYTHEMIA-INDUCING ISOLATES OF  FRIEND  SFFV 
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FiG.  2.  Titration of tissue culture-derived FV-A by the spleen focus assay. Tissue culture medium 
harvested from NIH/3T3 cells  chronically infected  with FV-A was assayed in 6-wk-old  DBA/2J 
mice for spleen focus-forming activity. Groups of six mice were injected intravenously with 0.25  ml 
of dilutions ofcuhure medium. Mice were killed  at day 9, the spleens fixed  in Bouin's solution and 
the number of macroscopic foci counted. 
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FtG.  3.  Effects  of FV-A and  FV-P on bone marrow and splenic erythroid colony formation with 
time after infection. DBA/2J mice were injected intravenously with 5 X  10  a FFU of FV-A (A, A) or 
FV-P (0, O) NIH/3T3 cell supernates at various times. The mice were sacrificed at the same time 
and  bone marrow and spleens were taken  and  plated  in  2-d  methylcellulose culture without the 
addition of EPO (a, ©) or in the presence of 0.50 U/ml EPO (A, 0). The symbols l, [] indicate the 
number of erythroid colonies/10  s nucleated cells obtained from the marrow or spleen of mice that 
were sacrificed  immediately after virus was injected  as determined with 0.50  U/ml of EPO (I) or 
without EPO (V]). MACDONALD ET AL.  1483 
Isolation and Characterization of Cell Clones Nonpmductivity Infected with SFFVA.  The 
observations that the NIH/3T3 cell clones productively infected with either FV-A or 
FV-P  contained  SFFV  (SFFVA  and  SFFVp),  and  that  FV-A  and  FV-P  induce 
different effects on erythroid progenitor cells, suggested that SFFVA and SFFVp may 
be biologically distinguishable and responsible for the two  forms of Friend disease 
observed in adult mice. To test this possibility, RAT-1 fibroblast cell clones nonpro- 
ductively infected with either SFFVA or SFFVp were isolated as described in Materials 
and Methods.  The defective SFFV genome present in these clones was rescued by 
superinfection with F-MuLVA or F-MuLVe and the rescued virus was injected into 
6-wk-old DBA/2J mice. As shown in Table II, infection of adult DBA/2J mice with 
SFFVp rescued from a RAT-1 cell clone nonproduetively  infected with SFFVp (RAT- 
1P-5)  with either F-MuLVA or F-MuLVp, resulted in polycythemia and a  marked 
increase in  the  number of both  EPO-dependent and  EPO-independent erythroid 
colony-forming  cells. In contrast, infection of adult DBA/2J mice with SFFVA rescued 
from a  RAT-1 cell clone nonproductively infected with SFFVA (RAT-1A-1) rescued 
with either F-MuLVA or F-MuLVp, resulted in anemia and an increase only in the 
number of EPO-dependent colony-forming cells.  As  shown  in  the  accompanying 
study (12), infection of adult mice with either F-MuLV^ or F-MuLVp alone did not 
result in any change in either the number, or EPO-dependence, of these erythroid 
progenitor cells, nor were changes in hematocrit or spleen weight detected. 
Comparison of Translational Products of the Anemia and Polycythemia Strains of SFFV.  To 
characterize  these two  isolates of SFFV further and identify possible differences in 
TABLE II 
Rescue of SFFVA and SFFVp  from RA T- 1 Nonproducer Clones* 
Number of eryth- 
roid colonies per 
Rescuing virus  Cell  Virus titer~  Spleen  Hemato-  10  s spleen cells; 
weight  crit  EPO (U/ml) 
0  0.5 
FFU/ml  g  % 
Mock§  RAT- 1  0  0.10  49  0  32 
F-MuLVA  RAT- 1  0  0.09  47  0  29 
F-MuLV~,  RAT- 1  0  0.11  49  0  54 
Mock  RAT- IA-  1  0  0.13  48  0  31 
F-MuLVA  RAT-IA-I  6.0 ×  103  1.37  38  55  1,693 
F-MuLVp  RAT-1A-I  1.6 X 103  0.88  40  12  1,053 
Mock  RAT- 1P-5  0  0.10  47  0  36 
F-MuLVA  RAT-IP-5  2.3 ×  103  1.53  68  2,520  4,864 
F-MuLVp  RAT-IP-5  5.2 X 103  2.61  76  3,983  6,841 
* DBA/2J mice were injected intravenously with a 1:5 dilution of culture fluid from RAT-1 nonproducer 
cell clones  that had been superinfected four cell passages earlier with F-MuLV^ or F-MuLVp as described 
in Materials and Methods. Spleen weight, hematocrit, and spleen erythroid colony formation were 
evaluated 25 d after infection as described in Materials and Methods. 
J~ DBA/2J mice were injected with various dilutions of the same culture fluid from superinfected RAT-1 
nonproducer clones that was used to determine hematocrit spleen weight and erythroid colony formation. 
Spleens were removed at day 9 and examined for foci. 
§ Mock-infected  mice received similar amounts of cuhure fluid from uninfected NIH/3T3 cells. 1484  ANEMIA-  AND POLYCYTHEMIA-INDUCING  ISOLATES OF FRIEND SFFV 
their genomic structure which might account for their biologic properties, the trans- 
lational products of SFFVA and SFFVp were studied.  RAT-1 cells  nonproductively 
infected with each strain were analyzed by competition immunoassay. As summarized 
in Table III, the SFFVA nonproducer cell clone, RAT-1A-1, expressed high levels  of 
the gag- and env-gene coded proteins p15, p12, p30, and gp70. In contrast, the SFFVp 
nonproducer cell clone, RAT-1P-5, was only reactive in the p 15 and gp70 assays. The 
specificity of  the reactivity observed is established by the lack of  detectable competition 
by uninfected RAT-1 cell extracts in any of the five assays and by the high level of 
expression of all four gag proteins, and gp70, in NIH/3T3 cells  productively infected 
with FV-P (9). 
SDS-PAGE and Tryptic Peptide Analysis of SFFV env-encoded Proteins.  The demonstra- 
tion of gp70 immunologic cross-reactivity in the RAT-1P-5 cell line is consistent with 
previous  reports  of a  55,000-mol  wt  glycoprotein encoded  by SFFVp  (22,  23).  To 
determine  whether  the  SFFVA  genome  also  encodes  a  55,000-mol  wt  env-related 
protein, RAT-1 cell lines nonproductively infected by the two isolates of SFFV were 
analyzed  by  [3~S]methionine  labeling  followed  by  immunoprecipitation  and  SDS- 
PAGE.  As  shown  in  Figure  4,  both  RAT-1A-1  and  RAT-1P-5  cells  contained  a 
protein of ~55,000 dahons that was immunoprecipitable by goat anti-Rauscher gp70 
but not  normal goat serum. The demonstration of a  55,000-mol wt protein  in both 
SFFV nonproductively infected cell lines, but not in uninfected RAT-1 cells, indicated 
that SFFVA, as well as SFFVp, encoded a 55,000-mol wt glycoprotein. 
The possibility that the env-related gp55 glycoprotein encoded by SFFVp is involved 
in the leukemogenic properties associated with this virus has been suggested (22, 24). 
It was therefore of interest to compare the [35S]methionine-containing tryptic peptide 
composition of the 55,000-mol wt proteins encoded by the anemia- and polycythemia- 
inducing strains  of SFFV.  As shown  in  Fig.  5A,  SFFVp-encoded gp55 contains  at 
least  eight well-resolved [35S]methionine-labeled tryptic peptides.  In contrast,  under 
similar conditions, SFFVA gp55 exhibited  three  labeled  peptides  (Fig.  5 B),  each of 
TABLE  III 
Type C Viral Antigen Expression in Rat-1  Cells Nonproductively Infected by 
SFFVa or SFFVp 
Viral antigen expression 
en~ 
Cell  gag-gene coded  gene 
coded 
p15  p12  p30  pl0  gp70 
ng/mg cellular protein 
RAT- 1  <20  <5  <2  < 10  <20 
RAT-1A-I  510  380  430  <10  120 
RAT-1P-5  320  <5  <2  <10  80 
NIH/3T3 (FV-P)  2,200  1,800  3,100  1,300  2,600 
Cell extracts, prepared as described in Materials and Methods, were tested at 
serial twofold  dilution in competition immunoassays  using goat anti-Rauscher 
a2~l  1  '  "  MuLV for precipitation of  - abeled structural proteins purified from the 
Rauscher strain of MuLV. Results are based on the extent of displacement of 
binding relative to  purified FV-P structural proteins and  represent mean 
values from duplicate determinations at each dilution tested. MACDONALD ET AL.  1485 
FIG. 4.  Immunoprecipitation  and  SDS-PAGE  analysis  of envelope  glycoproteins  expressed  in 
RAT-1 cells nonproductively-infected  by the anemia and polycythemia strains of SFFV. Cell lines 
(A, B) RAT-IA-I; (C, D) RAT- IP-5; and (E, F) control RAT-I (cells) were pulse-labeled in medium 
containing  [~S]methionine  (250 #Ci/ml) for 30 min, immunoprecipitated  by goat anti-Rauscher 
MuLV gpT0 (A, C, E) and normal goat serum (B, D, F), and analyzed by SDS-PAGE. Molecular 
weight standards  include  t4C-labeled phosphorylase  B (98,000), bovine serum  albumin  (69,000), 
ovalbumin  (46,000), carbonic anhydrase  (30,000), and cytochrome C (12,000). 
which  appears  to  correspond  in  mobility  to  tryptic  peptides  represented  in  SFFVp 
gp55.  To  demonstrate  further  the  relatedness  of the  SFFVA-  and  SFFVp-specific 
[~S]methionine-labeled  peptides, tryptic digests were mixed before analysis. As shown 
in  Fig.  5C,  the  three  major  peptides  specific  to  SFFVA  were  not  resolved  from  the 
corresponding  SFFVp peptides. 
Host  Genetic Control of Spleen Focus Formation and Anemzc Transformation by FV-A.  A 
number of host  genes,  including  W, SI, and Fv-2, are known  to govern susceptibility 
to FV-P  (25-28).  Mice  carrying  two  mutant  alleles  at  either  the  W  or  the  Sl locus 
(W/W v and  Sl/Sl a)  are  severely  anemic  (29-31)  and  exhibit  partial  resistance  to 
SFFVp-associated erythroleukemia and spleen focus formation. To determine whether 
these  loci  also  influence  susceptibility  to  FV-A,  normal  +/+  and  their  genetically Fie.  5.  [35S]Methionine tryptic peptide analysis of 55,000-mol  wt  glycoproteins encoded by  the 
anemia  and  polycythemia  strains  of SFFV.  [ZsS]Methionine-labeled  proteins  were  isolated  by 
immunoprecipitation and SDS-PAGE as described in the legend to Fig. 4.  Proteins were digested 
with TPCK-trypsin as described previously  (21).  Tryptic  digests  (6,000-10,000  cpm)  were resus- 
pended in electrophoresis buffer and spotted at  the origin (C)) on cellulose thin-layer glass plates. 
Separation in the first dimension was by electrophoresis and in the second by ascending chromatog- 
raphy. Samples included the 55,000-mol wt glycoproteins isolated from (A)  RAT-1P-5;  (B)  RAT- 
IA-1; and (C) the two proteins mixed at a ratio of 1:1. Individual peptides are designated a through 
h. 
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anemic W/W" and Sl/Sl a littermates were injected with FV-A or FV-P and examined 
after 9 d. The data summarized in Table IV demonstrate that these host loci conferred 
incomplete resistance to FV-A and FV-P, as determined by spleen weight and spleen 
focus formation. 
Fv-2 is  another major host  locus that  regulates susceptibility to erythroleukemia 
induction and spleen focus formation by FV-P (27). Fv-2 rr mice have been shown to 
be highly resistant  to the  induction  of splenomegaly and  spleen  foci  (27),  polyey- 
themia, and the appearance of EPO-independent erythroid progenitor cells (32). To 
determine whether the Fv-2 gene locus also controls susceptibility to FV-A, congenic 
B6  (Fv-2 "r)  and  B6.S  (Fv-2 "8)  mice were injected with  either FV-A or FV-P.  The 
results shown in Table V  demonstrate that B6.S (Fv-2 ~)  mice were fully susceptible 
to both FV-A and  FV-P.  In contrast,  infection of congenic B6  (Fv-2 '~)  mice with 
either FV-A or FV-P did not result in the appearance of spleen foci, splenomegaly, or 
changes in hematocrit; nor were any alterations observed in the number of erythroid 
colony-forming cells. Thus, the anemia- and polycythemia-inducing strains of Friend 
SFFV are both subject to regulation at the W, Sl, and Fv-2 gene loci. 
Discussion 
The results presented in this study indicate that the two SFFV activities present in 
stocks of FV-A and FV-P, SFFV^ and SFFVp, represent distinct, but related, viral 
TABLE  IV 
Susceptibility  of Normal and Genetically Anemic Mice to Induction  of Spleen 
Focus Formation and E~ythrolenkemia by FV-A and FV-P* 
Genotype  Virus  Virus titer:~  Spleen  Hemato- 
weight  crit 
+/+§ 
FFU/ml  g  % 
MockU  0  o. 10  52 
FV-P  1.2 ×  104  1.70  84 
FV-A  9.0 ×  l0  a  2.52  39 
Sl/Sl a  Mock  0  0.12  34 
FV-P  2 x  102  0.32  57 
FV-A  4.8 ×  102  0.98  10 
w/w  ~  Mock  0  0.11  36 
FV-P  3.5 ×  102  0.53  61 
FV-A  6 ×  102  1.10  13 
* Mice  were  injected  intravenously with  FV-A  and  FV-P  harvested  from 
cloned chronically infected NIH/3T3 fibroblasts. Spleen weight and bema- 
tocrit  were determined as described  in  Materials and Methods  16 d  after 
infection. 
:~ Mice were injected with various dilutions of the same cell-culture-derived 
preparations of FV-A and FV-P that were used to determine hematocrit and 
spleen weight.  Spleens were  removed and placed  in  Bouin's solution  and 
counted for spleen foci 9 d  after infection. 
§ As the data obtained for the +/+  littermates ofSl/Sl d and W~ W v mice were 
not significantly different, only the data obtained with the +/+  littermates 
ofSl/Sl d mice is shown. 
[I Mock-infected mice were injected with medium harvested from uninfected 
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TABLE V 
Susceptibih'ty of Fv-2 Congenic Mice to FV-A and FV-P * 
Hemato-  Mouse genotype  Virus  Virus titer~  crit 
Number of erythroid colonies per 
10  ~ cells 
Bone marrow 
cells  Spleen cells 
EPO (U/ml) 
0  0.5  0  0.5 
Fv-2 ~" (B6.S) 
FFU/ml  % 
Mock§  0  46  0  248  0  31 
FV-P  1.0X  104  78  270  863  3,180  4,029 
FV-A  4.0 X 103  38  0  136  22  860 
Fv-2  r~ (B6)  Mock  0  45  0  269  0  36 
FV-P  0  46  0  255  0  25 
FV-A  0  45  0  273  0  43 
* Mice  were injected  intravenously  with  FV-A and  FV-P harvested  from  cloned  chronically  infected 
NIH/3T3 fibroblasts. Hematocrit and erythroid colony formation were evaluated 25 d after infection as 
described in Materials and Methods. 
:~ Mice were injected with various dilutions of FV-A and FV-P derived from chronically infected NIH/3T3 
fibroblasts. The titers were determined 9 d after infection using the spleen focus assay (7). 
§ Mock infected mice received the same volume ofeuhure fluid from uninfected NIH/3T3 cells. 
isolates. Furthermore, these two isolates of SFFV appear to be the major determinants 
of at least the early stages of Friend disease: SFFVp induces polycythemia, whereas 
the disease associated with SFFVA is accompanied by anemia. Experiments in which 
SFFV nonproducer cell clones were rescued by different helper viruses demonstrated 
that the type of et3~throleukemia induced by SFFVA and SFFVp was independent of 
the source of the Friend helper virus. This conclusion is consistent with  the finding, 
presented in the accompanying study (12), that neither F-MuLVA nor F-MuLVp, the 
helper viruses used in this study, induced disease in adult DBA/2J  mice. 
The present studies also define further the cellular differences between the anemic 
and  polycythemic forms of Friend disease.  Infection of susceptible mice with  FV-P 
resulted in the appearance of large numbers  of EPO-independent  erythroid colony- 
forming cells in the marrow and spleen, in agreement with previous findings (5, 6). In 
contrast, infection of susceptible mice with FV-A produced a reduction in the number 
of EPO-dependent erythroid colony-forming cells in marrow and an increase in EPO- 
dependent  erythroid colony-forming cells in spleen.  The observation that  erythroid 
progenitor cells from  FV-A- but  not  FV-P-infected hemopoietic tissue retain  EPO 
dependence  has  also  been  observed  in  studies  using  FV-A  ([33];  B.  Fagg and  W. 
Ostertag. Personal communication.) and the anemia-inducing Rauscher MuLV  virus 
(34)  obtained from extracts of the spleens of infected mice. 
The conclusion that  FV-A and  FV-P induce  related diseases is further supported 
by the finding that a number of host genes that had previousiy been shown to control 
susceptibility to FV-P also govern susceptibility to FV-A. Anemic  W/W  °  mice have 
defective hematopoietic stem  cells which  are incapable of extensive proliferation or 
erythroid differentiation  (29,  30).  In  contrast,  genetically anemic  Sl/Sl a  mice  have 
been shown previously to have a defective hematopoietic environment which prevents MACDONALD  ET  AL.  1489 
extensive erythroid differentiation of normal hematopoietic stem cells (31)  and also 
confers  resistance  to  FV-P  (25,  28).  The  finding  that  genetic  defects  in  normal 
hemopoiesis result in a  decrease in susceptibility to both FV-A and FV-P suggests 
that these two isolates of Friend virus are subject to similar host regulatory mecha- 
nisms. 
The Fv-2 locus is another host genetic determinant that governs susceptibility to 
erythroleukemia induction by FV-P (27). As shown in our study, the Fv-2 gene locus 
also affects susceptibility to FV-A. All the in vivo and in vitro parameters of leukemic 
transformation induced by FV-A and FV-P that were tested--anemia or polycythemia 
induction, splenomegaly, spleen  focus formation, and changes  in  the  number and 
EPO responsiveness of erythroid progenitor colony-forming cells--were affected. The 
finding that the Fv-2 locus controls both spleen focus formation and these various 
hematological parameters suggests that the distinct SFFV activities present in FV-A 
and FV-P are responsible for the cellular changes observed in Friend virus-infected 
animals. 
Insight into the mechanism of resistance to viral replication and transformation 
mediated by Fv-2 may be derived from the observation that Fv-2 regulates levels of 
SFFVp-specific  RNA  sequences  in  both  uninfected and  infected  mice  (35).  This 
observation thus raises the question of whether the sequences specific to SFFVp are 
genetically related to or distinct from those specific to SFFVA. 
Further evidence that SFFVp and SFFVA represent genetically related, but distinct, 
transforming  viruses  derives  from  an  analysis  of their  translational  products.  In 
confirmation of our previous results (9), the gag region of SFFVp genome is shown to 
encode an amino-terminal type C  viral gag-gene protein, p15.  In contrast, gag-gene 
expression in SFFVA nonproducer cells is even more extensive, including p15, p 12, 
and p30 antigenic reactivities. These findings, in combination with previous obser- 
vations that  the gag gene of a  second clone of SFFVp encodes p15  and p12  (36), 
suggests that the extent of gag-gene expression is highly variable between different 
SFFV isolates and indicates that the intracistronic arrangement of the Friend SFFV 
gag genes, 5'-p 15-p 12-p30-p 10-3', is analogous to that of other MuLV isolates (37, 38). 
This study also demonstrates that both SFFVp and SFFVA encode 55,000-mol wt 
env-gene  products,  designated  gp55.  The  gp55  of SFFVp  includes  at  least  eight 
methionine-containing peptides, only three of which are represented in SFFVA gp55. 
This finding is consistent with previous suggestions that the env region of the SFFV 
genome  may  include  sequences  involved  in  erythroleukemia  induction  (22,  24). 
Historically, SFFVp appears to be derived from SFFVA. Thus, if the env gene does 
include transforming sequences, the transition from anemia to polycythemia induction 
may be associated with differences in env-gene products of the two SFFV isolates as 
described in this study. 
Summary 
Two distinct clones of Friend spleen focus-forming virus (SFFV), differing in their 
erythroleukemic potential, are described. These isolates have been cloned free of their 
associated helper viruses and shown to be replication-defective. Both SFFV isolates 
have been rescued from rat fibroblast nonproducer cell clones with cloned replication- 
competent viruses, F-MuLVA and F-MuLVp, obtained from the anemia- or polycy- 
themia-inducing isolates of Friend virus complex, respectively. These rescued viruses 1490  ANEMIA- AND  POLYCYTHEMIA-INDUCING  ISOLATES  OF  FRIEND SFFV 
induce  a  rapid  proliferative  disease  associated  with  the  appearance  of macroscopic 
spleen foci and splenomegaly. In addition, each is subject to regulation by the  W, Steel 
(Sl), and Fv-2 host gene loci. These two isolates of SFFV can, however, be distinguished 
by both biological and molecular criteria. Friend SFFVp induces a rapid polycythemia 
associated with the appearance of large numbers oferythropoietin (EPO)-independent 
erythroid colony-forming cells in the marrow and spleen.  In contrast, SFFVA induces 
a  rapid  anemia  associated  with  a  progressive  decrease  in  the  number  of EPO- 
dependent  erythroid  colony-forming cells  in  marrow,  and  a  rapid  increase  in  the 
number of EPO-dependent erythroid colony-forming cells in spleen. Furthermore, the 
nature of the disease induced by the two isolates of SFFV is independent of the Friend 
helper virus: SFFVp, rescued from a nonproducer cell clone with either F-MuLVA or 
F-MuLVp,  induced  a  polycythemic  transformation,  whereas  SFFVA,  rescued  with 
either  F-MuLVA or F-MuLVp, induced  an  anemic  transformation.  The two Friend 
SFFV isolates can also be discriminated on the basis of translational products encoded 
by their gag and env genes: SFFVp encodes the amino-terminal gag-gene  protein p15, 
whereas  SFFVA encodes  the gag-gene  proteins  p15,  p12,  and  p30.  In  addition,  the 
SFFV isolates encode nonidentical  55,000-mol wt env gene-related  proteins  that  can 
be distinguished  by analysis of their methionine-containing  tryptic peptides. 
The authors wish to thank Dr. C. Friend for providing a preparation of FV-A. We also thank 
Dr.  A.  A.  Axelrad  for helpful  discussions  during  the preparation  of an  earlier  form of this 
manuscript, and Dr. G. Johnson for his assistance with the erythroid culture assays. 
Received for publication 30 August 1979 and in revised  form 26 February 1980. 
References 
1.  Friend, C. 1957. Cell-free transmission in adult Swiss mice of a disease  having the character 
of a leukemia..].  Exp.  Med.  105:307. 
2.  Metcalfe, D., J. Furth, and R. F. Buffet.  1959. Pathogenesis of mouse leukemia caused by 
Friend virus.  Cancer Res.  19:52. 
3.  Mirand, E. A. 1968. Murine viral-induced polycythemia. Ann.  N.  Y. Acad.  Sci.  149:486. 
4.  Mirand,  E.  A.,  R.  A.  Steeves,  R.  D.  Lange,  and  J.  T.  Grace.  1968. Virus-induced 
polycythemia in mice: erythropoiesis without erythropoietin. Proc. Soc, Exp.  BioL  Med.  128: 
844. 
5.  Liao, S.  K.,  and  A.  A.  Axelrad.  1975. Erythropoietin-independent  erythroid colony for- 
mation in vitro by hemopoietic cells of mice infected with Friend virus. Int. dr. Cancer. 15:467. 
6.  Horoszewicz, J. S., S. S. Leong, and W. A. Carter.  1975. Friend leukemia: rapid develop- 
ment of erythropoietin-independent hematopoietic precursors.d  r. Natl.  Cancer Inst. 54:265. 
7.  Axelrad, A. A., and R. A. Steeves.  1964. Assay for Friend leukemia virus: rapid quantitative 
method based on enumeration of macroscopic spleen foci in mice.  Virology. 24:513. 
8.  Steeves,  R. A., R. J. Eckner, M. Bennett, E. A. Mirand, and P. J. Trudel.  1971. Isolation 
and characterization of a lymphatic leukemia virus in the Friend leukemia virus complex. 
dr. Natl. Cancer Inst. 46:1209. 
9.  Bernstein,  A., T. W. Mak, andJ. R. Stephenson.  1977. The Friend virus genome: evidence 
for the stable association of MuLV sequences and sequences involved in erythroleukemic 
transformation. Cell.  12:287. 
10.  Troxler, D. H.,J. K. Boyars, W. P. Parks, and E. M. Scolnick. 1977. Friend strain of spleen 
focus-forming virus: a recombinant between mouse ecotropic viral sequences and sequences 
related to xenotropic virus.dr.  Virol. 22:361. MACDONALD ET AL.  1491 
11.  Mirand, E. A., R. A. Steeves,  L. Avila, and J. T. Grace, Jr.  1968. Spleen focus formation 
by polycythemic strains of Friend leukemia virus. Proc. Soc. Exp. Biol. Med.  127:900. 
12.  MacDonald, M. E., T. W. Mak, and A. Bernstein.  1980. Erythroleukemia induction by 
replication-competent type C viruses cloned from the anemia- and polycythemia-inducing 
isolates of Friend leukemia virus.J. Exp. Meal. 151:1493. 
13.  Axelrad, A., M. Ware, and H. C. van der Gaag. 1972. In: RNA Viruses and Host Genome 
in Oncogenesis. P.  Emmelot and  P.  Bentvelzen, editors.  North Holland Publishing Co., 
Amsterdam. 239. 
14. Jainchill,  J.  E.,  S.  Aaronson,  and  G. J.  Todaro.  1969. Murine  sarcoma  and  leukemia 
viruses:  assay using clonal lines of contact-inhibited mouse cells. J.  Virol. 4:.549. 
15.  Prassad, I., D. Zouzias, and C. Basilico.  1976. State of viral DNA in rat cells transformed 
by polyoma virus. I. Virus rescue and the presence of nonintegrated viral DNA molecules. 
J.  Virol. 18:436. 
16.  Stanners,  C.  P.,  G.  L.  Eliceiri,  and  H.  Green.  1971. Two types of ribosomes  in  mouse- 
hamster hybrid cells. Nat. New Biol. 250:52. 
17.  Rowe, W. P., W. E.  Pugh, and J. W. Hartley.  1970. Plaque assay techniques for routine 
leukemia viruses.  Virology. 42:1136. 
18.  Iscove, N. N., and F. Sieber.  1975. Erythroid progenitors in mouse bone marrow detected 
by macroscopic colony formation in culture. Exp. Hematol. (Oak Ridge). 3:32. 
19.  Stephenson, J. R., A. A. Axelrad, D. L. McLeod, and M. M. Shreeve.  1971. Induction of 
colonies of hemoglobin-synthesizing cells by erythropoietin in vitro. Proc. Natl. Acad. Sci. U. 
S. A. 68:1542. 
20.  Stephenson, J. R., R. K. Reynolds, S. G. Devara, and F. H. Reynolds, Jr. 1977. Biochemical 
and immunological properties of gag gene coded structural proteins of endogenous type C 
RNA tumor viruses of diverse mammalian species.J.  Biol. Chem. 252:7818. 
21.  Van de Ven, W. J. M., A. S. Khan, F. H. Reynolds, Jr., K. T. Maron, and J. R. Stephenson. 
Translational  products encoded by newly acquired  sequences  of independently  derived 
feline sarcoma virus isolates  are structurally related.J.  Virol. In press. 
22.  Ruscetti,  S.,  D.  Linemeyer, J.  Field,  D.  Troxler,  and  E.  Scolnick.  1978.  Type-specific 
radioimmunoassays  for  the  gp70s  of mink  cell  focus-inducing  murine  leukemia  virus: 
expression of a cross-reacting antigen in cells infected with the Friend strain of the spleen 
focus-forming virus.J. Exp. Med. 148:654. 
23.  Dresler,  S.,  M.  Ruta, M. J.  Murray, and  D.  Kabat.  1979. Glyeoprotein encoded by the 
Friend spleen focus-forming virus. J.  Virol. 30:.564. 
24.  Ruscetti, S., D. Troxler, D. Linemeyer, and E. Scolnick.  1980. Three laboratory strains of 
spleen  focus-forming virus:  comparison of their  genomes and  translational  products. J. 
Virol. 33:14,0. 
25.  Bennett, M., R. A. Steeves, G. Cudkowicz, E. A. Mirand, and L. B. Russell.  1968. Mutant 
Sl alleles  of mice affect susceptibility to Friend spleen focus-forming virus.  Science (Wash. 
D. C.).  162:564. 
26.  Steeves,  R. A., M. Bennett, E. A. Mirand, and G. Cudkowicz. 1968. Genetic control by the 
W locus of susceptibility to (Friend) spleen focus forming virus. Nature (Lond.).  218:372. 
27.  Lilly, F.  1970. Fv-2: identification arlcl location of a second gene governing the spleen focus 
response to Friend leukemia virus in mice.J. Natl.  Cancer Inst. 45:163. 
28.  McCool,  D.,  T.  W.  Mak,  and  A.  Bernstein.  1979.  Cellular  regulation  in  Friend  virus 
induced erythroleukemia: studies with anemic mice of genotype SI/SI a. J. Exp.  Med. 149:. 
837. 
29.  Russell,  E. S.  1970. Abnormalities of erythropoiesis associated with mutant genes in mice. 
In Regulation of Hematopoiesis. A. S. Gordon, editor Appleton-Century-Crofts, New York. 
649. 1492  ANEMIA-  AND  POLYCYTHEMIA-INDUCING  ISOLATES OF FRIEND SFFV 
30.  McCulloch, E. A., L. Siminovitch, and J. E. Till. 1964. Spleen colony formation in anemic 
mice of genotype W/W °. Science (Wash, D.  C.).  144:844. 
31.  McCulloch, E. A., L. Siminovitch, J. E. Till, E. S. Russell, and S. E. Bernstein.  1965. The 
cellular basis of the genetically determined hemopoietic defect in anemic mice of genotype 
Sl/Sl d. Blood. 26:399. 
32.  Axelrad, A. A., S. Suzuki, H. van der Gaag, B. J. Clarke, and D. L. McLeod. 1978. Friend 
virus and malignant erythropoiesis: a genetic analysis. In: ICN-UCLA Syrup. Mol.  Cell, Biol. 
10:69. 
33.  Steinheider, G., H. J.  Seidel, and L. Kreja.  1979. Comparison of the biological effects of 
anemia- and polycythemia-inducing Friend virus complex. Experientia  (Basel). 35:1173. 
34.  Hasthorpe, S., and S. Bol. 1979. Erythropoietin responses and physical characterization of 
erythroid progenitor cells in Rauscher virus infected Balb/c mice. J.  Cell. Physiol.  100:77. 
35.  Mak, T. W., A. A. Axelrad, and A. Bernstein.  1979. The Fv-2 locus controls expression of 
Friend spleen focus-forming virus specific sequences in normal and infected mice. Proc. Natl. 
Acad. Sci. U. S. A.  76:5809. 
36.  Barbacid,  M.,  D.  H.  Troxler,  E.  M.  Scolnick,  and  S.  A.  Aaronson.  1978. Analysis of 
translational products of Friend strain of spleen focus-forming virus.J.  Virol. 27:826. 
37.  Reynolds, R. K., and J. R. Stephenson.  1977. Intracistronic mapping of the murine type- 
C viral gag gene by use of conditional lethal replication mutants.  Virology. 81:328. 
38.  Barbacid, M., J.  R. Stephenson, and S. A. Aaronson.  1976. The gag gene of mammalian 
type-C RNA tumor viruses. Nature  (Lond.).  262:554. 